← All trials
NCT04970446
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2021
- Primary completion
- Dec 1, 2022
- Completion date
- Dec 1, 2023
- First posted
- Jul 21, 2021
- Last posted
- Jul 21, 2021
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of New South WalesLead sponsor
- University of QueenslandCollaborator
- University of New South WalesReponsible party - principal investigator
- University of AdelaideCollaborator
- Monash UniversityCollaborator
- BiomeBank AdelaideCollaborator
- St. Vincents HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.